vatelizumab								9439

Structure	 

Heavy chain / Chaone lourde / Cadena pesada

QVQLQESGPG LVKPSETLSL TCTVSGFSLT NYGIHWIRQP PGKGLEWLGV  50

IWARGFTNYN SALMSRLTIS KDNSKNQVSL KLSSVTAADT AVYYCARAND 100

GVYYAMDYWG QGTLVTVSSA STKGPSVFPL APCSRSTSES TAALGCLVKD 150

YFPEPVTVSW NSGALTSGVH TFPAVLQSSG LYSLSSVVTV PSSSLGTKTY 200

TCNVDHKPSN TKVDKRVESK YGPPCPSCPA PEFLGGPSVF LFPPKPKDTL 250

MISRTPEVTC VVVDVSQEDP EVQFNWYVDG VEVHNAKTKP REEQFNSTYR 300

VVSVLTVLHQ DWLNGKEYKC KVSNKGLPSS IEKTISKAKG QPREPQVYTL 350

PPSQEEMTKN QVSLTCLVKG FYPSDIAVEW ESNGQPENNY KTTPPVLDSD 400

GSFFLYSRLT VDKSRWQEGN VFSCSVMHEA LHNHYTQKSL SLSLGK     446

Light chain / Chaone lygire / Cadena ligera

DFVMTQSPAF LSVTPGEKVT ITCSAQSSVN YIHWYQQKPD QAPKKLIYDT  50

SKLASGVPSR FSGSGSGTDY TFTISSLEAE DAATYYCQQW TTNPLTFGQG 100

TKVEIKRTVA APSVFIFPPS DEQLKSGTAS VVCLLNNFYP REAKVQWKVD 150

NALQSGNSQE SVTEQDSKDS TYSLSSTLTL SKADYEKHKV YACEVTHQGL 200

SSPVTKSFNR GEC                                         213

Disulfide bridges location / Position des ponts disulfure / Posiciones
de los puentes disulfuro

Intra-H	22-95	146-202	260-320	366-424

	22??-95??	146??-202??	260??-320??	366??-424??

Intra-L	23?-87?	133?-193?



	23???-87???	133???-193???



Inter-H-L	133-213?	133??-213???



Inter-H-H	225-225??	228-228??





N-glycosylation sites / Sites de N-glycosylation / Posiciones de
N-glicosilaciun

296, 296??

	

WHO 

International Nonproprietary Names Programme	

30/06/2011



		

